8-K ·Filed Sep 14, 2026

DXCM

DEXCOM INC
NEUTRAL
Impact 2/10
Horizonmonths Processed17d 15h ago SEC0001093557-26-000175
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

This is a routine organizational change with no immediate financial impact. Monitor the next 10-Q for any operational efficiency metrics or margin commentary that may result from the expanded COO role.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+5d
DXCM ▲ +3.56% at T+5d
NEUTRAL call ✓ call won +3.56% · α vs SPY +1.44% · entry $86.45 → $89.53
Next anchor: T+20d in 10d
Latest observation: T+10 +3.83% FF3 residual α
Entry anchored
Sep 14, 04:19 PM ET
via 1-min bar
T+1d
+1.03%
call +1.03% · α +1.47%
$87.34
settled 17d ago
T+5d
+3.56%
call +3.56% · α +1.44%
$89.53
settled 11d ago
T+20d
—
call — · α —
—
in 10d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

DexCom promoted CFO Jereme Sylvain to also serve as COO, effective September 14, 2026. His new offer letter provides an annual base salary of $767,000 and a 75% target bonus. This is a routine internal promotion combining finance and operations oversight, with no financial data or guidance provided.

Key Facts

  • Jereme Sylvain promoted to EVP, Chief Operating Officer and Chief Financial Officer, effective September 14, 2026.
  • New annual base salary of $767,000 and annual target bonus opportunity equal to 75% of base salary.
  • Sylvain will assume oversight of global operations and quality teams in addition to his CFO duties.

Financial Impact

No financial figures reported; compensation details are routine.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (36 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001093557-26-000175
Document: dxcm20260914-exhibit991.htm0001093557-26-000175
Document: 0001093557-26-000175-index-headers.html0001093557-26-000175
Document: 0001093557-26-000175-index.html0001093557-26-000175
Document: 0001093557-26-000175.txt0001093557-26-000175
11 reports for DXCM
Performance horizon
Filters
Rows
Reports for DXCM — sortable, filterable
TypeNow
Sep 14, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$86.45 $89.53▲ +3.56%▲ +1.44%$86.23 (−0.25%)
Aug 28, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.06 $84.53▼ −7.17%▼ −7.03%$86.23 (−5.30%)
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.06 $91.06· 0.00%▼ −0.47%$86.23 (−5.30%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$88.76 $91.06▲ +2.59%▲ +3.78%$86.23 (−2.85%)
Jul 21, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.43 $75.14▲ +5.19%▲ +7.60%$86.23 (+20.72%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$72.47 $68.65▼ −5.27%▼ −3.61%$86.23 (+18.99%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$70.17 $73.45▲ +4.67%▲ +3.46%$86.23 (+22.88%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$70.17 $72.70▲ +3.61%▲ +3.14%$86.23 (+22.88%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.24 $72.27▲ +1.45%▼ −0.36%$86.23 (+21.04%)
Apr 15, 2026
24w ago
DEFA14A
NEUTRAL ★ 2/10
$61.01 $62.68▲ +2.74%▲ +1.75%$86.23 (+41.33%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access